Toshiaki Takakura

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Sentinel Lymph Node

Top Venues

Japanese journal of clinical oncology

Respirology case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Toshiaki Takakura, Toshio Shimizu, Nobuyuki Yamamoto
Antibody-drug conjugates in solid tumors; new strategy for cancer therapy. Japanese journal of clinical oncology 54 (8) (2024)
Toshiaki Takakura, Hiroaki Akamatsu, Atsushi Washioka, Eriko Murakami, Ryota Shibaki, Toshio Shimizu, Yasuhiro Koh, Nobuyuki Yamamoto
Unsuccessful rechallenge with nivolumab in a patient with advanced non-small cell lung cancer who had a 6-year complete response and treatment-free period: Case report. Respirology case reports 12 (9) (2024)
Toshiaki Takakura, Toshio Shimizu, Nobuyuki Yamamoto
Antibody-drug conjugates in solid tumors; new strategy for cancer therapy. Japanese journal of clinical oncology 54 (8) (2024)
Toshiaki Takakura, Toshio Shimizu, Nobuyuki Yamamoto
Antibody-drug conjugates in solid tumors; new strategy for cancer therapy. Japanese journal of clinical oncology 54 (8) (2024)
Hideto Iguchi, Hiroaki Akamatsu, Yoshimitsu Hirai, Takahito Nakaya, Aya Fusamoto, Yumi Yata, Takahiro Nagai, Daiki Kitahara, Toshiaki Takakura, Yoshiharu Nishimura, Nobuyuki Yamamoto
Can FDG-PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non-small cell lung cancer? Respirology case reports 12 (8) (2024)
Toshiaki Takakura, Toshio Shimizu, Nobuyuki Yamamoto
Antibody-drug conjugates in solid tumors; new strategy for cancer therapy. Japanese journal of clinical oncology 54 (8) (2024)
Hideto Iguchi, Hiroaki Akamatsu, Yoshimitsu Hirai, Takahito Nakaya, Aya Fusamoto, Yumi Yata, Takahiro Nagai, Daiki Kitahara, Toshiaki Takakura, Yoshiharu Nishimura, Nobuyuki Yamamoto
Can FDG-PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non-small cell lung cancer? Respirology case reports 12 (8) (2024)
Toshiaki Takakura, Toshio Shimizu, Nobuyuki Yamamoto
Antibody-drug conjugates in solid tumors; new strategy for cancer therapy. Japanese journal of clinical oncology (2024)
Toshiaki Takakura, Hiroaki Akamatsu, Atsushi Washioka, Eriko Murakami, Ryota Shibaki, Toshio Shimizu, Yasuhiro Koh, Nobuyuki Yamamoto
Unsuccessful rechallenge with nivolumab in a patient with advanced non-small cell lung cancer who had a 6-year complete response and treatment-free period: Case report. Respirology case reports 12 (9) (2024)